First 100 Reported Cases of Supine Percutaneous Nephrolithotomy in Malaysia: An Alternative Effective and Safe Approach to Treat Renal Stones
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Supine percutaneous nephrolithotomy (s-PCNL) is a safe and effective treatment for kidney stones. Middle calyceal access offers the best stone clearance, and s-PCNL is recommended for combined procedures.
Area Of Science
- Urology
- Nephrology
- Surgical Innovation
Background
- Supine percutaneous nephrolithotomy (s-PCNL) presents advantages in urological and anesthetic management.
- This study evaluates the initial outcomes of s-PCNL in Malaysia.
- Assessing the safety and efficacy of s-PCNL is crucial for its adoption.
Purpose Of The Study
- To evaluate the safety and efficacy of supine percutaneous nephrolithotomy (s-PCNL).
- To compare outcomes based on renal access site (upper, middle, lower calyx).
- To assess the feasibility of s-PCNL in combination with other endourological procedures.
Main Methods
- Retrospective review of 115 patients undergoing s-PCNL for renal pelvis stones.
- Data collected on stone-free rates, complications, blood transfusions, operative time, and length of stay.
- Analysis included patients with simultaneous ipsilateral or contralateral endourological procedures.
Main Results
- Stone-free rates were highest with single middle calyceal access (MCA).
- Major complications were low across all access groups (UCA, MCA, LCA).
- One patient (0.9%) required a blood transfusion; mean length of stay was 2.9 days.
Conclusions
- s-PCNL is a safe and effective treatment for renal stones.
- s-PCNL is time-efficient for patients needing combined procedures (URS/RIRS).
- Single MCA is recommended for optimal stone clearance.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.